Chocolate company Hershey (NYSE:HSY) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 10.6% year on year ...

Hershey beat first-quarter earnings estimates, driven partly by an 8% jump in Ice Breakers gum and mint sales linked to rising GLP-1 drug use. CEO Kirk Tanner highlighted 'functional snacking' as a ...

Health Canada has approved a second generic version of Ozempic, made by Toronto-based Apotex, just days after authorizing the first generic from India’s Dr. Reddy’s Laboratories. The move is expected ...

The Hershey Company (NYSE: HSY) today announced net sales and earnings for the first quarter ended March 29, 2026 and ...

People using high-profile weight-loss drugs aren't just changing how they eat—they're reshaping the candy aisle. Hershey says ...

Hershey’s CEO says an 8% sales jump in Ice Breakers mints and gum is tied to GLP‑1 weight‑loss drug use, which can cause bad breath. The drugs, including Ozempic, Wegovy and Mounjaro, slow digestion ...

The growing use of GLP-1 weight loss drugs is influencing both consumer habits and health research. Food companies like Hershey report rising sales of mints, gum, and protein bars linked to users ...

Health Canada has approved a second generic version of semaglutide, the drug in Ozempic, just days after the first, making Canada the first G7 country to do so. The move is expected to lower costs ...

Southern Miss pitching combined for 35 strikeouts, tying a school record in the nightcap, as the 12th-ranked Golden Eagles ...

Health Canada has approved a second generic version of Ozempic, this time from Canadian firm Apotex, just days after the first generic was cleared. The move is expected to lower prices and expand ...

GLP-1 weight-loss drugs are not only reducing appetite but also driving unexpected market changes, such as increased gum and mint sales tied to side effects like dry mouth. New large-scale research ...